Related Experiment Video
Updated: Aug 30, 2026
An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model
Published on: January 13, 2023
Choroidal hemangioma treated with photodynamic therapy using verteporfin: report of a case
M Nicolò1, D Ghiglione, A Polizzi
1Department of Neurology, University Eye Clinic of Genova, Genova, Italy. massimonicolo@iol.it
Purpose:
To report the results of treatment of circumscribed choroidal hemangioma with a single application of photodynamic therapy (PDT) with verteporfin according to the Treatment of Age-related Macular Degeneration with Photodynamic Therapy study.
Methods:
A 44-year-old man with unilateral decreased vision and macular subretinal fluid secondary to a circumscribed choroidal hemangioma diagnosed by fluorescein and indocyanine green angiography and ultrasonography underwent PDT with verteporfin therapy.
Results:
One year after PDT, subretinal fluid was absent and visual acuity improved.
Conclusions:
The results obtained in this case are in keeping with previously reported results; however, future randomized studies are necessary to evaluate and standardize different infusion times in order to obtain maximum efficacy of treatment.
